Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
12 2021
Historique:
received: 26 10 2021
accepted: 10 11 2021
revised: 17 12 2021
pubmed: 8 12 2021
medline: 19 2 2022
entrez: 7 12 2021
Statut: epublish

Résumé

HIV-1 replication within the central nervous system (CNS) impairs neurocognitive function and has the potential to establish persistent, compartmentalized viral reservoirs. The origins of HIV-1 detected in the CNS compartment are unknown, including whether cells within the cerebrospinal fluid (CSF) produce virus. We measured viral RNA+ cells in CSF from acutely infected macaques longitudinally and people living with early stages of acute HIV-1. Active viral transcription (spliced viral RNA) was present in CSF CD4+ T cells as early as four weeks post-SHIV infection, and among all acute HIV-1 specimens (N = 6; Fiebig III/IV). Replication-inactive CD4+ T cell infection, indicated by unspliced viral RNA in the absence of spliced viral RNA, was even more prevalent, present in CSF of >50% macaques and human CSF at ~10-fold higher frequency than productive infection. Infection levels were similar between CSF and peripheral blood (and lymph nodes in macaques), indicating comparable T cell infection across these compartments. In addition, surface markers of activation were increased on CSF T cells and monocytes and correlated with CSF soluble markers of inflammation. These studies provide direct evidence of HIV-1 replication in CD4+ T cells and broad immune activation in peripheral blood and the CNS during acute infection, likely contributing to early neuroinflammation and reservoir seeding. Thus, early initiation of antiretroviral therapy may not be able to prevent establishment of CNS viral reservoirs and sources of long-term inflammation, important targets for HIV-1 cure and therapeutic strategies.

Identifiants

pubmed: 34874976
doi: 10.1371/journal.ppat.1010105
pii: PPATHOGENS-D-21-02144
pmc: PMC8683024
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1010105

Subventions

Organisme : NIAID NIH HHS
ID : AAI20052001
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH106466
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS084911
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Immunol. 2001 Nov 1;167(9):5429-38
pubmed: 11673562
J Neurovirol. 1996 Dec;2(6):423-32
pubmed: 8972425
PLoS One. 2015 Oct 02;10(10):e0139510
pubmed: 26431315
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007120
pubmed: 22675662
J Neuroimmunol. 2005 Nov;168(1-2):154-63
pubmed: 16091292
AIDS. 2020 Jul 15;34(9):1289-1301
pubmed: 32598115
J Infect Dis. 2018 Aug 14;218(6):937-945
pubmed: 29741638
J Virol. 1999 Dec;73(12):10480-8
pubmed: 10559366
J Virus Erad. 2016;2:43-48
pubmed: 26889497
PLoS One. 2014 Oct 23;9(10):e110731
pubmed: 25340755
Clin Infect Dis. 2016 Aug 15;63(4):555-61
pubmed: 27317797
Nat Rev Neurol. 2016 May;12(5):309
pubmed: 27080521
J Virol. 2007 Nov;81(21):12040-8
pubmed: 17715237
J Infect Dis. 2012 Jul 15;206(2):275-82
pubmed: 22551810
Science. 1998 Apr 17;280(5362):427-31
pubmed: 9545219
Am J Pathol. 1991 Sep;139(3):609-21
pubmed: 1716047
Mol Neurobiol. 2019 May;56(5):3808-3818
pubmed: 30209774
PLoS Pathog. 2017 Jun 27;13(6):e1006445
pubmed: 28654687
Am J Pathol. 2004 Jun;164(6):2089-99
pubmed: 15161643
J Virol. 2010 Mar;84(5):2395-407
pubmed: 20015984
PLoS One. 2015 Feb 26;10(2):e0116526
pubmed: 25719800
AIDS. 2003 Sep 5;17(13):1871-9
pubmed: 12960819
J Immunol Methods. 2013 May 31;391(1-2):133-45
pubmed: 23500781
J Exp Med. 2001 Apr 16;193(8):905-15
pubmed: 11304551
Proc Natl Acad Sci U S A. 1986 Sep;83(18):7089-93
pubmed: 3018755
Clin Infect Dis. 2019 Sep 27;69(8):1345-1352
pubmed: 30561541
Ann Clin Transl Neurol. 2015 Sep;2(9):906-19
pubmed: 26401512
PLoS One. 2013 Jun 18;8(6):e66188
pubmed: 23822975
Nat Med. 2009 Aug;15(8):893-900
pubmed: 19543283
Am J Pathol. 2011 May;178(5):2121-35
pubmed: 21514427
Am J Pathol. 1991 Dec;139(6):1273-80
pubmed: 1750503
AIDS Res Hum Retroviruses. 1998 Sep 1;14(13):1181-6
pubmed: 9737589
PLoS Pathog. 2015 Mar 26;11(3):e1004720
pubmed: 25811757
Neurol Clin. 2018 Nov;36(4):751-765
pubmed: 30366553
Science. 1986 Sep 5;233(4768):1089-93
pubmed: 3016903
PLoS Pathog. 2017 Aug 7;13(8):e1006538
pubmed: 28787449
J Neurovirol. 2011 Feb;17(1):63-9
pubmed: 21246320
J Infect Dis. 2019 Nov 6;220(12):1885-1891
pubmed: 30668739
PLoS Pathog. 2021 Sep 23;17(9):e1009871
pubmed: 34555123
J Neurol. 2014 Jan;261(1):130-43
pubmed: 24162037
Nat Commun. 2020 Jan 14;11(1):272
pubmed: 31937782
J Med Primatol. 2005 Oct;34(5-6):303-12
pubmed: 16128925
Am J Pathol. 2015 Jun;185(6):1649-65
pubmed: 25963554
Am J Pathol. 2017 Jun;187(6):1436
pubmed: 28527711
AIDS Res Hum Retroviruses. 2015 Jul;31(7):696-706
pubmed: 25891017
J Leukoc Biol. 2010 Apr;87(4):557-67
pubmed: 19843579
Am J Pathol. 1998 Mar;152(3):659-65
pubmed: 9502406
J Virol. 2018 May 14;92(11):
pubmed: 29563297
Nat Med. 2018 Jul;24(7):923-926
pubmed: 29892063
AIDS. 2019 Feb 1;33(2):163-184
pubmed: 29547440
J Infect Dis. 2011 Jul 1;204(1):135-8
pubmed: 21628667
Cells. 2019 Aug 15;8(8):
pubmed: 31443253
J Acquir Immune Defic Syndr. 2017 May 1;75(1):108-117
pubmed: 28177966
Brain Pathol. 2002 Oct;12(4):442-55
pubmed: 12408230
AIDS. 2015 Apr 24;29(7):755-66
pubmed: 25985398
J Virol. 2006 Sep;80(17):8729-38
pubmed: 16912320
J Exp Med. 2004 Sep 20;200(6):761-70
pubmed: 15365095
AIDS. 2016 Jan;30(2):203-10
pubmed: 26684817
J Infect Dis. 2013 Jul;208(1):50-6
pubmed: 23089590
PLoS One. 2009 Dec 17;4(12):e8129
pubmed: 20019816
Science. 1988 Feb 5;239(4840):586-92
pubmed: 3277272
J Virol. 2014 Nov;88(21):12385-96
pubmed: 25122785

Auteurs

Vishakha Sharma (V)

Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.

Matthew Creegan (M)

Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.

Andrey Tokarev (A)

Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.

Denise Hsu (D)

Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.

Bonnie M Slike (BM)

Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.

Carlo Sacdalan (C)

Institute of HIV Research and Innovation, Bangkok, Thailand.

Phillip Chan (P)

Institute of HIV Research and Innovation, Bangkok, Thailand.

Serena Spudich (S)

Department of Neurology, Yale University, New Haven, Connecticut, United States of America.

Jintanat Ananworanich (J)

Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.

Michael A Eller (MA)

Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.

Shelly J Krebs (SJ)

Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.

Sandhya Vasan (S)

Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.

Diane L Bolton (DL)

Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH